Lymphoma, T-Cell
Showing 9976 - 10000 of >10,000
Type 2 Diabetes Trial in Worldwide (HOE901-U300 (new formulation of insulin glargine), Lantus (insulin glargine))
Completed
- Type 2 Diabetes Mellitus
- HOE901-U300 (new formulation of insulin glargine)
- Lantus (insulin glargine)
-
Chandler, Arizona
- +192 more
Mar 15, 2022
Healthy Trial in Mannheim (BI 1291583, Itraconazole)
Completed
- Healthy
- BI 1291583
- Itraconazole
-
Mannheim, GermanyCRS Clinical Research Services Mannheim GmbH
Nov 9, 2021
Heart Failure Trial in Copenhagen Ø (Cardiology Stem Cell Centre Adipose Stem Cell (CSCC_ASC), Placebo)
Completed
- Heart Failure
- Cardiology Stem Cell Centre Adipose Stem Cell (CSCC_ASC)
- Placebo
-
Copenhagen Ø, DenmarkCardiac Catheterization Laboratory 2014, The Heart Centre, Unive
Sep 2, 2022
Non Small Cell Lung Cancer Trial in United States (HBI-8000 in combination with pembrolizumab)
Active, not recruiting
- Non Small Cell Lung Cancer
- HBI-8000 in combination with pembrolizumab
-
Goodyear, Arizona
- +6 more
Dec 5, 2022
Lymphoma, B-Cell, Lymphoma, Non-Hodgkin Trial in Park Ridge (CLOFARABINE)
Completed
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
-
Park Ridge, IllinoisOncology Specialists, SC
Oct 24, 2017
Recurrent Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in United States (ChemoID Assay, Standard Chemotherapy)
Recruiting
- Recurrent Ovarian Carcinoma
- Platinum-resistant Ovarian Cancer
- ChemoID Assay
- Standard Chemotherapy
-
Phoenix, Arizona
- +9 more
Oct 16, 2021
Violence by Teachers Trial in Cap-Haitien (Interaction Competencies with Children - for Teachers (ICC-T))
Recruiting
- Violence by Teachers
- Interaction Competencies with Children - for Teachers (ICC-T)
-
Cap-Haitien, HaitiP4H Global
Dec 14, 2021
Metastatic, Melanoma, Non Small Cell Lung Cancer (NSCLC) Trial in Philadelphia (Radiotherapy, MEDI4736, Tremelimumab)
Active, not recruiting
- Metastatic
- +4 more
- Radiotherapy
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jan 6, 2023
Diphtheria, Tetanus, Pertussis Trial in Thai Binh (Hexaxim®)
Completed
- Diphtheria
- +5 more
- Hexaxim®
-
Thai Binh, VietnamPreventive Medicine Centre of Thai Binh Province
Mar 24, 2022
Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug
Enrolling by invitation
- Cerebral Adrenoleukodystrophy (CALD)
- +2 more
- Lenti-D
-
Los Angeles, California
- +10 more
Nov 4, 2022
CNS Tumor, Infantile Fibrosarcoma, Recurrent Acute Leukemia Trial in Canada, United States (Larotrectinib Sulfate)
Active, not recruiting
- Central Nervous System Neoplasm
- +4 more
- Larotrectinib Sulfate
-
Birmingham, Alabama
- +81 more
Jan 24, 2023
Hepatitis B, Chronic Trial in Worldwide (Midazolam, Placebo, RO7049389)
Completed
- Hepatitis B, Chronic
- Midazolam
- +2 more
-
Herston, Queensland, Australia
- +20 more
Jul 7, 2022
COPD Co-infection With Tuberculosis on Th17 Cell Differentiation
Completed
- Tuberculosis Infection
- Chronic Obstructive Pulmonary Disease
- No intervention
-
Beijing, Beijing, ChinaPeking University Third Hospital
Jul 14, 2021
Nipple Neurotization
Completed
- Breast Reconstruction
-
Taoyuan, TaiwanChangGungMH
Jun 7, 2023
Small Cell Lung Cancer Trial in Saint Louis (AL8326 low dose group, AL8326 middle dose group, AL8326 high dose group)
Recruiting
- Small Cell Lung Cancer
- AL8326 low dose group
- +2 more
-
Saint Louis, MissouriSiteman cancer center, Washington University
Nov 1, 2022
Edentulous; Alveolar Process, Atrophy Trial in Salamanca (dental implant with transepithelial abutments manufactured by
Completed
- Edentulous; Alveolar Process, Atrophy
- dental implant with transepithelial abutments manufactured by Galimplant Dental System (Spain)
-
Salamanca, SpainClinica Odontológica de la Universidad de Salamanca
Mar 8, 2022
Other Cancer Trial in United States (Shared Care, Standard Care)
Completed
- Other Cancer
- Shared Care
- Standard Care
-
Stamford, Connecticut
- +8 more
Nov 1, 2022
Microenvironment of Lung Cancer and Exploration of Mechanism of
Recruiting
- Lung Cancer
- Multiomics analysis
-
Yiwu, Zhejiang, ChinaThe Fourth Affiliated Hospital of Zhejiang University
Dec 16, 2022
Metastatic Squamous Non-Small Cell Lung Carcinoma Trial in Chicago (Cabozantinib 40 MG, Pembrolizumab 200mg)
Recruiting
- Metastatic Squamous Non-Small Cell Lung Carcinoma
- Cabozantinib 40 MG
- Pembrolizumab 200mg
-
Chicago, IllinoisUniversity of Illinois at Chicago
Jan 20, 2023
MDS Trial in Worldwide (MBG453, Placebo, Hypomethylating agents)
Active, not recruiting
- Myelodysplastic Syndromes
- MBG453
- +2 more
-
Duarte, California
- +46 more
Jan 20, 2023
Squamous Cell Carcinoma of the Head and Neck (SCCHN) Trial in Worldwide (palbociclib, Cetuximab, Placebo)
Completed
- Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- palbociclib
- +2 more
-
La Jolla, California
- +70 more
Oct 10, 2022
Ovarian Clear Cell Carcinoma, Gynecologic Cancer Trial in Boston (Lenvatinib, Pembrolizumab)
Recruiting
- Ovarian Clear Cell Carcinoma
- Gynecologic Cancer
-
Boston, MassachusettsDana Farber Cancer Institute
Oct 13, 2022
Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +
Recruiting
- Gastric Cancer
- +9 more
- Tumor Infiltrating Lymphocytes (TIL)
- Fludarabine + Cyclophosphamide combination
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 21, 2022
Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha
Terminated
- Essential Thrombocythemia
- +3 more
- Diagnostic (18F-FLT PET/CT)
-
Doha, QatarNational Center for Cancer Care & Research (NCCCR)
Aug 10, 2020
Lung Cancer, Metastatic Cancer Trial in Detroit (Cryotherapy (PTC), Prednisone)
Completed
- Lung Cancer
- Metastatic Cancer
- Cryotherapy (PTC)
- Prednisone
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Oct 29, 2022